INSR and breast cancer: In a transgenic model of pancreatic neuroendocrine carcinogenesis and an oestrogen-unresponsive breast cancer cell line, insulin receptor knockdown had no effect alone but sensitised cells to pharmacological inhibition of the type I IGF receptor [47].